BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38483604)

  • 21. Glycogen metabolism in brain and neurons - astrocytes metabolic cooperation can be altered by pre- and neonatal lead (Pb) exposure.
    Baranowska-Bosiacka I; Falkowska A; Gutowska I; Gąssowska M; Kolasa-Wołosiuk A; Tarnowski M; Chibowska K; Goschorska M; Lubkowska A; Chlubek D
    Toxicology; 2017 Sep; 390():146-158. PubMed ID: 28916327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PELI1: key players in the oncogenic characteristics of pancreatic Cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling.
    Huang L; Chen S; Fan H; Ji D; Chen C; Sheng W
    Cancer Gene Ther; 2021 Aug; 28(7-8):839-849. PubMed ID: 32747685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling.
    Dang C; Bian Q; Wang F; Wang H; Liang Z
    Sci Rep; 2024 Jan; 14(1):2116. PubMed ID: 38267509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.
    Cao M; Zhang PB; Wu PF; Chen Q; Ge WL; Shi GD; Yin J; Cai BB; Cao SJ; Miao Y; Jiang KR
    Biomed Res Int; 2021; 2021():6530298. PubMed ID: 33748270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
    Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
    Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
    Sheng W; Chen C; Dong M; Zhou J; Liu Q; Dong Q; Li F
    J Cell Physiol; 2014 Jul; 229(7):887-97. PubMed ID: 24264800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway.
    Cao X; Yao N; Zhao Z; Fu Y; Hu Y; Zhu P; Shi W; Tang L
    Bioengineered; 2022 Mar; 13(3):7771-7784. PubMed ID: 35286235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
    Sheng W; Chen C; Dong M; Wang G; Zhou J; Song H; Li Y; Zhang J; Ding S
    Cell Death Dis; 2017 Oct; 8(10):e3147. PubMed ID: 29072694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
    Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
    Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
    [No Abstract]   [Full Text] [Related]  

  • 33. PMEPA1 Stimulates the Proliferation, Colony Formation of Pancreatic Cancer Cells via the MAPK Signaling Pathway.
    Song M; Zhou B; Li B; Tian L
    Am J Med Sci; 2021 Sep; 362(3):291-296. PubMed ID: 33857498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling.
    Chen Y; Liu P; Shen D; Liu H; Xu L; Wang J; Shen D; Sun H; Wu H
    Biol Open; 2020 Feb; 9(2):. PubMed ID: 31988090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and
    Yu Y; Wang Y; Zou Y; Yu Y
    Dis Markers; 2022; 2022():5286820. PubMed ID: 35707714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis.
    Liu QG; Li YJ; Yao L
    Pancreatology; 2018 Sep; 18(6):678-688. PubMed ID: 30055941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain-Type Glycogen Phosphorylase Is Crucial for Astrocytic Glycogen Accumulation in Chronic Social Defeat Stress-Induced Depression in Mice.
    Zhu Y; Fan Z; Zhao Q; Li J; Cai G; Wang R; Liang Y; Lu N; Kang J; Luo D; Tao H; Li Y; Huang J; Wu S
    Front Mol Neurosci; 2021; 14():819440. PubMed ID: 35140588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.
    Altemus MA; Goo LE; Little AC; Yates JA; Cheriyan HG; Wu ZF; Merajver SD
    PLoS One; 2019; 14(9):e0220973. PubMed ID: 31536495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node metastasis related gene BICC1 promotes tumor progression by promoting EMT and immune infiltration in pancreatic cancer.
    Meng F; Hua S; Chen X; Meng N; Lan T
    BMC Med Genomics; 2023 Oct; 16(1):263. PubMed ID: 37880742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
    Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.